Indian Peptides and Heparin Market to Grow at 4.9% CAGR to 2022

ReportsnReports offers a global report on “Indian Peptides and Heparin Market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 85 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.

Get Sample Copy of Indian Peptides and Heparin Market at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1162821

The Indian Peptides Market is expected to reach USD 883.0 Million in 2022 from USD 381.8 Million in 2016 and is expected to register a CAGR of 15.0%, and the Indian Heparin Market is projected to reach USD 170.2 Million by 2022, at a CAGR of 4.9%.

Top Companies Profiled n the Indian Peptides and Heparin Market:

  • Sanofi (France)
  • Emcure Pharmaceutical Pvt. Ltd. (India)
  • Cipla Ltd. (India)
  • Bharat Serum (India)
  • Pfizer Inc. (U.S.)
  • Abbott Laboratories (U.S.)
  • Lupin Ltd. (India)
  • Reddy’s Laboratories (India)
  • Intas Pharmaceuticals Ltd. (India)
  • Samarth Life Sciences (India)
  • Claris Lifesciences Limited (India)
  • Gland Pharma Limited (India)
  • Mylan Pharmaceutical (India)
  • Torrent Pharmaceuticals (India)
  • Micro Labs Ltd. (India)
  • VHB Life sciences (India)

The Indian peptides market is classified on the basis of type into insulin, teriparatide, liraglutide, glucagon, leuprolide acetate, octreotide acetate, calcitonin salmon, triptorelin, eptifibatide, glatiramer acetate, bivalirudin, exenatide, and other molecules. The bivalirudin segment is expected to register the highest CAGR during the forecast period.

By application, the Indian peptides market is segmented into diabetes, infectious disease, cancer, cardiology, osteoporosis, gynecological applications, and other applications. The diabetes segment is expected to register highest CAGR during the forecast period. The growth in this segment can be primarily attributed to increasing awareness of early diagnosis, increasing prevalence & incidence of diabetes, and increasing aging population.

Access full report with all information @ https://www.reportsnreports.com/purchase.aspx?name=1162821

Share This Post